Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'OSTEOCLAST DIFFERENTIATION FACTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 68 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Halladay, DL; Miles, RR; Thirunavukkarasu, K; Chandrasekhar, S; Martin, TJ; Onyia, JE
      Identification of signal transduction pathways and promoter sequences thatmediate parathyroid hormone 1-38 inhibition of osteoprotegerin gene expression

      JOURNAL OF CELLULAR BIOCHEMISTRY
    2. Komine, M; Kukita, A; Kukita, T; Ogata, Y; Hotokebuchi, T; Kohashi, O
      Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappa B ligand in generation of osteoclasts in stromal cell-depletedrat bone marrow cell culture

      BONE
    3. Watkins, BA; Li, Y; Lippman, HE; Seifert, MF
      Omega-3 polyunsaturated fatty acids and skeletal health

      EXPERIMENTAL BIOLOGY AND MEDICINE
    4. Chabaud, M; Lubberts, E; Joosten, L; van den Berg, W; Miossec, P
      IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis

      ARTHRITIS RESEARCH
    5. Gravallese, EM; Galson, DL; Goldring, SR; Auron, PE
      The role of TNF-receptor family members and other TRAF-dependent receptorsin bone resorption

      ARTHRITIS RESEARCH
    6. Kostenuik, PJ; Shalhoub, V
      Osteoprotegerin: A physiological and pharmacological inhibitor of bone resorption

      CURRENT PHARMACEUTICAL DESIGN
    7. Disthabanchong, S; Gonzalez, EA
      Regulation of bone cell development and function: Implications for renal osteodystrophy

      JOURNAL OF INVESTIGATIVE MEDICINE
    8. Hofbauer, LC; Heufelder, AE
      Role of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin in bone cell biology

      JOURNAL OF MOLECULAR MEDICINE-JMM
    9. Eguchi, K
      Apoptosis in autoimmune diseases

      INTERNAL MEDICINE
    10. Fazzalari, NL; Kuliwaba, JS; Atkins, GJ; Forwood, MR; Findlay, DM
      The ratio of messenger RNA levels of receptor activator of nuclear factor kappa B ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis

      JOURNAL OF BONE AND MINERAL RESEARCH
    11. Zhang, XP; Morham, SG; Langenbach, R; Young, DA; Xing, LP; Boyce, BF; Puzas, EJ; Rosier, RN; O'Keefe, RJ; Schwarz, EM
      Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis

      JOURNAL OF BONE AND MINERAL RESEARCH
    12. Childs, LM; Goater, JJ; O'Keefe, RJ; Schwarz, EM
      Efficacy of etanercept for wear debris-induced osteolysis

      JOURNAL OF BONE AND MINERAL RESEARCH
    13. Konttinen, YT; Takagi, M; Mandelin, J; Lassus, J; Salo, J; Ainola, M; Li, TF; Virtanen, I; Liljestrom, M; Sakai, H; Kobayashi, Y; Sorsa, T; Lappalainen, R; Demulder, A; Santavirta, S
      Acid attack and cathepsin K in bone resorption around total hip replacement prosthesis

      JOURNAL OF BONE AND MINERAL RESEARCH
    14. Watkins, BA; Li, Y; Seifert, MF
      Nutraceutical fatty acids as biochemical and molecular modulators of skeletal biology

      JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
    15. Grcevic, D; Katavic, V; Lukic, IK; Kovacic, N; Lorenzo, JA; Marusic, A
      Cellular and molecular interactions between immune system and bone

      CROATIAN MEDICAL JOURNAL
    16. Hofbauer, LC; Heufelder, AE; Erben, RG
      Osteoprotegerin, RANK, and RANK ligand: The good, the bad, and the ugly inrheumatoid arthritis

      JOURNAL OF RHEUMATOLOGY
    17. Skapenko, A; Kalden, JR; Schulze-Koops, H
      Treatment of rheumatoid arthritis in the third millennium

      SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    18. Fan, X; Fan, D; Gewant, H; Royce, CL; Nanes, MS; Rubin, J
      Increasing membrane-bound MCSF does not enhance OPGL-driven osteoclastogenesis from marrow cells

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    19. Sparks, AB; Peterson, SN; Bell, C; Loftus, BJ; Hocking, L; Cahill, DP; Frassica, FJ; Streeten, EA; Levine, MA; Fraser, CM; Adams, MD; Broder, S; Venter, JC; Kinzler, KW; Vogelstein, B; Ralston, SH
      Mutation screening of the TNFRSF11A gene encoding receptor activator of NFkappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma

      CALCIFIED TISSUE INTERNATIONAL
    20. Watkins, BA; Lippman, HE; Le Bouteiller, L; Li, Y; Seifert, MF
      Bioactive fatty acids: role in bone biology and bone cell function

      PROGRESS IN LIPID RESEARCH
    21. Roodman, GD
      Studies in Paget's disease and their relevance to oncology

      SEMINARS IN ONCOLOGY
    22. Kitazawa, R; Kitazawa, S
      Gene expression during fracture healing in normal mouse: In situ hybridization on hard tissues for investigation of regenerative mechanisms

      ACTA HISTOCHEMICA ET CYTOCHEMICA
    23. Shiotani, A; Shibasaki, Y; Sasaki, T
      Localization of receptor activator of NF kappa B ligand, RANKL, in periodontal tissues during experimental movement of rat molars

      JOURNAL OF ELECTRON MICROSCOPY
    24. Schlondorff, J; Lum, L; Blobel, CP
      Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    25. Ma, YFL; Cain, RL; Halladay, DL; Yang, XH; Zeng, QQ; Miles, RR; Chandrasekhar, S; Martin, TJ; Onyia, JE
      Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation

      ENDOCRINOLOGY
    26. Kostenuik, PJ; Capparelli, C; Morony, S; Adamu, S; Shimamoto, G; Shen, V; Lacey, DL; Dunstan, CR
      OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats

      ENDOCRINOLOGY
    27. Oyajobi, BO; Anderson, DM; Traianedes, K; Williams, PJ; Yoneda, T; Mundy, GR
      Therapeutic efficacy of a soluble receptor activator of nuclear factor kappa B-IgG Fc fusion protein in suppressing bone resorption and hypercalcemiain a model of humoral hypercalcemia of malignancy

      CANCER RESEARCH
    28. Hofbauer, LC; Neubauer, A; Heufelder, AE
      Receptor activator of nuclear factor-kappa B ligand and osteoprotegerin - Potential implications for the pathogenesis and treatment of malignant bonediseases

      CANCER
    29. Mackle, PS; Fisher, JS; Zhou, H; Choong, PFM
      Bisphosphonates regulate cell growth and gene expression in the UMR 106-01clonal rat osteosarcoma cell line

      BRITISH JOURNAL OF CANCER
    30. Takeuchi, T; Tsuboi, T; Arai, M; Togari, A
      Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells

      BIOCHEMICAL PHARMACOLOGY
    31. Yano, K; Shibata, O; Mizuno, A; Kobayashi, F; Higashio, K; Morinaga, T; Tsuda, E
      Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF): Possible role of OPG/OCIF in the prevention of osteoporosis in pregnancy

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    32. Makiishi-Shimobayashi, C; Tsujimura, T; Iwasaki, T; Yamada, N; Sugihara, A; Okamura, H; Hayashi, S; Terada, N
      Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    33. Hofbauer, LC; Heufelder, AE
      The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis

      ARTHRITIS AND RHEUMATISM
    34. Komuro, H; Olee, T; Kuhn, K; Quach, J; Brinson, DC; Shikhman, A; Valbracht, J; Creighton-Achermann, L; Lotz, M
      The osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand system in cartilage

      ARTHRITIS AND RHEUMATISM
    35. Schett, G; Hayer, S; Tohidast-Akrad, M; Schmid, BJ; Lang, S; Turk, B; Kainberger, F; Haralambous, S; Kollias, G; Newby, AC; Xu, QB; Steiner, G; Smolen, J
      Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice

      ARTHRITIS AND RHEUMATISM
    36. Oshiro, T; Shibasaki, Y; Martin, TJ; Sasaki, T
      Immunolocalization of vacuolar-type H+-ATPase, cathepsin K, matrix metalloproteinase-9, and receptor activator of NFkB ligand in odontoclasts during physiological root resorption of human deciduous teeth

      ANATOMICAL RECORD
    37. Pettit, AR; Ji, H; von Stechow, D; Muller, R; Goldring, SR; Choi, YW; Benoist, C; Gravallese, EM
      TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

      AMERICAN JOURNAL OF PATHOLOGY
    38. Hofbauer, LC; Heufelder, AE
      Osteoprotegerin ligands and osteoprotegerin: new concepts of the pathogenesis and treatment of metabolic bone diseases

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    39. Neale, SD; Smith, R; Wass, JAH; Athanasou, NA
      Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D-3 and RANKL

      BONE
    40. Watkins, BA; Li, Y; Seifert, MF
      Dietary omega-3 fatty acids and bone health

      CURRENT ORGANIC CHEMISTRY
    41. Marie, P; Debiais, F; Cohen-Solal, M; de Vernejoul, MC
      New factors controlling bone remodeling

      JOINT BONE SPINE
    42. Holliday, LS; Gluck, SL; Slatopolsky, E; Brown, AJ
      1,25-dihydroxy-19-nor-vitamin D-2, a vitamin D analog with reduced bone resorbing activity in vitro

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    43. Gonzalez, EA
      The role of cytokines in skeletal remodelling: possible consequences for renal osteodystrophy

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    44. Onyia, JE; Miles, RR; Yang, X; Halladay, DL; Hale, J; Glasebrook, A; McClure, D; Seno, G; Churgay, L; Chandrasekhar, S; Martin, TJ
      In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene

      JOURNAL OF BONE AND MINERAL RESEARCH
    45. Riggs, BL; Baron, R; Boyle, WJ; Drezner, M; Manolagas, S; Martin, TJ; Stewart, AF; Suda, T; Yasuda, H; Aubin, J; Goltzman, D
      Proposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption

      JOURNAL OF BONE AND MINERAL RESEARCH
    46. Xu, JK; Tan, JW; Huang, L; Gao, XH; Laird, R; Liu, D; Wysocki, S; Zheng, MH
      Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappa B ligand

      JOURNAL OF BONE AND MINERAL RESEARCH
    47. Rubin, J; Fan, D; Wade, A; Murphy, TC; Gewant, H; Nanes, MS; Fan, X; Moerenhout, M; Hofstetter, W
      Transcriptional regulation of the expression of macrophage colony stimulating factor

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    48. Yamane, T; Kunisada, T; Yamazaki, H; Nakano, T; Orkin, SH; Hayashi, SI
      Sequential requirements for SCL/tal-1, GATA-2, macrophage colony-stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development

      EXPERIMENTAL HEMATOLOGY
    49. Manolagas, SC
      Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis

      ENDOCRINE REVIEWS
    50. Futami, T; Fujii, N; Ohnishi, H; Taguchi, N; Kusakari, H; Ohshima, H; Maeda, T
      Tissue response to titanium implants in the rat maxilla: Ultrastructural and histochemical observations of the bone-titanium interface

      JOURNAL OF PERIODONTOLOGY
    51. Wise, GE; Lumpkin, SJ; Huang, H; Zhang, Q
      Osteoprotegerin and osteoclast differentiation factor in tooth eruption

      JOURNAL OF DENTAL RESEARCH
    52. Mancini, L; Moradi-Bidhendi, N; Brandi, ML; Perretti, M; MacIntyre, I
      Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    53. Takeyama, S; Yoshimura, Y; Shirai, Y; Deyama, Y; Hasegawa, T; Yawaka, Y; Kikuiri, T; Matsumoto, A; Fukuda, H
      Low calcium environment effects osteoprotegerin ligand/osteoclast differentiation factor

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    54. Nagai, M; Kyakumoto, S; Sato, N
      Cancer cells responsible for humoral hypercalcemia express mRNA encoding asecreted form of ODF/TRANCE that induces osteoclast formation

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    55. Gravallese, EM; Goldring, SR
      Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis

      ARTHRITIS AND RHEUMATISM
    56. Cohen-Solal, M; Marie, P; De Vernejoul, MC
      Pathophysiological and genetic basis of osteoporosis.

      ANNALES DE MEDECINE INTERNE
    57. Kataoka, M; Torisu, T; Tsumura, H; Hirayama, T; Fujikawa, Y
      Role of multinuclear cells in granulation tissue in osteomyelitis - Immunohistochemistry in 66 patients

      ACTA ORTHOPAEDICA SCANDINAVICA
    58. Hoshi, K; Komori, T; Ozawa, H
      Morphological characterization of skeletal cells in Cbfa1-deficient mice

      BONE
    59. Udagawa, N; Takahashi, N; Jimi, E; Matsuzaki, K; Tsurukai, T; Itoh, K; Nakagawa, N; Yasuda, H; Goto, M; Tsuda, E; Higashio, K; Gillespie, MT; Martin, TJ; Suda, T
      Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor

      BONE
    60. Kartsogiannis, V; Zhou, H; Horwood, NJ; Thomas, RJ; Hards, DK; Quinn, JMW; Niforas, P; Ng, KW; Martin, TJ; Gillespie, MT
      Localization of RANKL (Receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues

      BONE
    61. Mannstadt, M; Juppner, H; Gardella, TJ
      Receptors for PTH and PTHrP: their biological importance and functional properties

      AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    62. Greenfield, EM; Bi, YM; Miyauchi, A
      Regulation of osteoclast activity

      LIFE SCIENCES
    63. Ali, NN; Gilston, V; Winyard, PG
      Activation of NF-kappa B in human osteoblasts by stimulators of bone resorption

      FEBS LETTERS
    64. Manolagas, SC
      Editorial: Cell number versus cell vigor - What really matters to a regenerating skeleton?

      ENDOCRINOLOGY
    65. Hofbauer, LC; Gori, F; Riggs, BL; Lacey, DL; Dunstan, CR; Spelsberg, TC; Khosla, S
      Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis

      ENDOCRINOLOGY
    66. Grey, A; Mitnick, MA; Masiukiewicz, U; Sun, BH; Rudikoff, S; Jilka, RL; Manolagas, SC; Insogna, K
      A role for interleukin-6 in parathyroid hormone-induced bone resorption invivo

      ENDOCRINOLOGY
    67. Ito, H; Akiyama, H; Shigeno, C; Iyama, K; Matsuoka, H; Nakamura, T
      Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    68. Akatsu, T; Murakami, T; Ono, K; Nishikawa, M; Tsuda, E; Mochizuki, SI; Fujise, N; Higashio, K; Motoyoshi, K; Yamamoto, M; Nagata, N
      Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy

      BONE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 06:58:09